EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF COLEUS VETTIVEROIDES ROOTS ON EXPERIMENTALLY INDUCED HEPATO TOXIC MODELS
HTML Full TextEVALUATION OF HEPATOPROTECTIVE ACTIVITY OF COLEUS VETTIVEROIDES ROOTS ON EXPERIMENTALLY INDUCED HEPATO TOXIC MODELS
A. Abarnadevika * and T. R. Nisha
KMCH College of Pharmacy, Affiliated by the Tamil Nadu Dr. MGR Medical University, Coimbatore - 641048, Tamil Nadu, India.
ABSTRACT: The present study was aimed to assess the hepatoprotective activity of ethanolic extract of Coleus vettiveroides on experimentally induced hepatotoxic models. Phytochemical screening of EECV was carried out and the results showed the presence of carbohydrates, alkaloids, tannin, flavonoids, phenolics, proteins and aminoacid, steroids and triterpenoids. HPTLC screening of EECV was carried out along with different marker compounds to ensure the presence of phytoconstituents such as Quercetin, Rutin, and Gallic acid. Antioxidant activities of the herbal extract were determined using both DPPH and ABTS scavenging method. MTT assay is most widely used to determine the cytotoxic potential of medicinal agents and other toxic materials. It was observed that for different concentrations of EECV, the cell viability was greater than 90%. In-vitro hepatoprotective activity of EECV was evaluated on Hep G2 cells, the human hepatoma cell line. In Hep G2 treatment with EECV (12.5, 25, 50, 100 and 200 μg/ml) the cell viability was above 90% indicating that EECV showed no cytotoxicity up to 200 μg/ml. Evaluation of biochemical parameters showed a significant increase in the activities of AST, ALT, and ALP that indicates increased permeability, severe damage to hepatocytes after exposing to CCl4. In the present study, hepatotoxicity model in Wistar rats was successfully produced by administering INH and RIF (15 and 10 mg/kg respectively) orally. The protective effects of EECV were further confirmed by histopathological examination of the livers, showing marked protection against liver tissue damage, normal lobular architecture, dilated sinusoidal spaces and vacuolization as compared to controls.
Keywords: |
Coleus Vettiveroides, Hepatotoxicity, Antioxidant, Silibinin
INTRODUCTION: The liver is one of the largest organs in the body weighing about 1.5 kg. It is by far the largest gland. It is included amongst the accessory organs of the alimentary system because it produces a secretion, called bile, which is poured into the duodenum (through the bile duct) and assists in the digestive process.
All the blood circulating through the capillary bed of the abdominal part of the alimentary canal (excepting the lower part of the anal canal) reaches the liver through the portal vein and its tributaries. In this way, all substances absorbed into the blood from the stomach and intestines are filtered through the liver, where some of them are stored; and some toxic substances may be destroyed.
Numerous other functions essential to the wellbeing of the individual are performed in the liver, which is, therefore, regarded as one of the vital organs. The liver lies in the upper, right part of the abdominal cavity. It lies mainly in the right hypochondrium and the epigastrium, but part of it extends into the left hypochondrium and part of it into the right lateral region. In general, hepatotoxic chemicals engender some reactive species, which form a covalent bond with the lipid which is responsible for damage liver cells 1. Another most used hepatotoxic agent relating to liver disorders is ethanol (alcohol) 2. In liver during the process of elimination, there is a chance of accumulation of different kinds of toxic materials inside the hepatocytes, and there is a chance of liver infection, and hepatic disorders such as hepatitis 3. Even though different kind of allopathic molecules are available in the market all of them are suffering from some are the other toxic effect, so the need of developing a herbal medicine which has got both liver-protecting and nutritional value is required hence an attempt has been made to screen the hepatoprotective activity of roots of Coleus vettiveroides.
MATERIALS AND METHODS:
Plant Collection and Authentication: The roots of the plant of Coleus vettiveroides Jacob was collected from Tirunelveli district, Tamil Nadu, India. Taxonomic identification was done by a Botanist of Central Council for Research in Ayurveda and Siddha. (Reference - Flora of Tamil Nadu Vol. 2 Page 183, 1987). The plant was washed to remove all debris and was shade-dried. The dried plant material was made to coarse powder.
Extraction of the Plant Material: 4 The extraction of the roots of Coleus vettiveroides was done by using a Soxhlet apparatus. The coarse powders of the roots were extracted with ethanol. After extraction, the ethanolic extract of Coleus vettiveroides (EECV) was evaporated or concentrated by using rotary evaporator and dried at room temperature to give a viscous mass. The obtained crude extracts were weighed and stored at 40 ºC for further analysis.
In-vitro-Antioxidant Studies:
DPPH Radical Scavenging Assay: 5, 6 The antioxidant activity of the extract was measured in terms of hydrogen donating or radical scavenging ability using the stable DPPH radical (Blois method). 0.3 mm solution of DPPH in ethanol was prepared and 1 ml of this solution was added to 1 ml of various concentrations of sample (10, 20, 40, 60, 80 and 100 μg/ml) and the reference compound (5, 10, 15, 20, 25 and 30 μg/ml), shaken vigorously, left to stand in the dark at room temperature for 30 min and then absorbance was measured at 517 nm against a blank. Reference compound used here was quercetin. A control reaction was carried out without the test sample. All the tests were performed in triplicate in order to get the mean values.
The percentage of inhibition was calculated by comparing the absorbance values of the control and test samples. The antiradical activity was expressed as percentage inhibition (I%) and calculated using the following equation.
Percentage inhibition (I %) = (Abs control - Abs sample /Abs control) × 100
Different sample concentrations were used in order to obtain calibration curves and to calculate the IC50 values. (IC50 - concentration required to obtain a 50% radical scavenging activity).
Abts Radical Scavenging Assay: 7, 8 ABTS radical scavenging activity of the extract was measured by Rice-Evans method. ABTS was dissolved in water to a 7 mm concentration. ABTS radical cation (ABTS+) was produced by reacting ABTS stock solution with 2.45 mm potassium persulfate and allowing the mixture to stand in the dark at room temperature for 12 - 16 h before use. The radical was stable in this form for more than 2 days when stored in the dark at room temperature. For the study, the ABTS solution was diluted with phosphate buffer saline pH 7.4 (PBS) to an absorbance of 0.70 (± 0.02) at 734 nm and equilibrated at 30 ºC. Reference compound used here was quercetin.
After addition of 1 ml of diluted ABTS+ solution to various concentrations of sample (5, 10, 15, 20, 25 and 30 µg/ml) and reference compound (0.25, 0.5, 0.75, 1, 1.25 and 1.5 µg/ml), the reaction mixture was incubated for 6min and then absorbance was measured at 734 nm against a blank. A control reaction was carried out without the sample. All the tests were performed in triplicate in order to get the mean values. The percentage inhibition of ABTS+ by the sample was calculated according to the formula:
Percentage inhibition (I %) = (Abs control - Abs sample / Abs control) × 100
Determination of In-vitro Cell Viability by MTT Assay: 8, 9
Cell Culture: Human liver hepatoma cells (Hep G2) were grown in Eagles Minimum Essentials Medium (EMEM) containing 10% fetal bovine serum (FBS). Cells were maintained at 37 ºC, 5% CO2, 95% air and 100% relative humidity. Cells were subcultured every third day by trypsinization with Trypsin-EDTA solution and medium changed daily.
Procedure: The monolayer cell culture was trypsinized to make single-cell suspensions and viable cells were counted using a hemocytometer and the cell count was adjusted to 2 × 104 cells per ml using EMEM containing 10% fetal bovine serum. To each well of 96 well microtiter plates, 0.1 ml of diluted cell suspension approximately 20,000 cells per well was added. After 24 h, when the monolayer formed the supernatant was flicked off and 100 μl of different test compounds at serial concentration was added to the cells in microtitre plates and kept for incubation at 37 ºC in 5% CO2 incubator for 48 h.
After 48 h, the sample solution in wells was flicked off and 15 μl of MTT dye (5 mg/ml) in phosphate-buffered saline was added to each well. The plates were gently shaken and incubated for 4 h at 37 ºC in 5% CO2 incubator. The supernatant was removed, 100 μl of DMSO was added, and the plates were gently shaken to solubilize the formed formazan. The absorbance was measured at 570 nm using microplate reader. The medium without samples was served as control and triplicates were maintained for all concentrations.
The percentage of cell viability was then calculated by using equation,
% Cell viability = Absorbance of treated cells / Absorbance of control × 100
In-vitro Hepatoprotective Activity: 10, 11 Hep G2 cells were plated at a density of 2 × 104 cells per well in medium containing 10% FBS incubated for 24 h at 37 ºC under 5% CO2 to attain confluency. On attaining confluency the medium was replaced with serum-free medium containing different concentrations of extract and standard silybinin along with toxicant carbon tetrachloride (CCl4 -1%) for 4 h and viability of cells was determined by MTT assay.
Experimental Design:
Group I (Control): The cells were treated with 100 μl of serum-free culture medium for 4 h.
Group II (Toxin Treatment): The cells were treated with 100 μl of serum-free medium containing 1% CCl4 for 4 h.
Group III (Silibinin Treatment): The cells were treated with 100 μl of serum-free medium containing 1% CCl4 with silybinin at a concentration of 50, 100 and 200 μg/ml for 4 h.
Group IV (Extract Treatment): The cells were treated with 100 μl of serum-free culture medium containing 1% CCl4 with EECV at concentration of 50, 100 and 200 μg/ml for 4 h.
In-vivo Hepatoprotective Activity:
Animals and Management: Male Wistar rats of 6-8 weeks old and 160 - 180 g body weight were offered by KMCH College of Pharmacy, Coimbatore. All rats were kept at room temperature and allowed to accommodate in standard conditions at 12 h light and 12 h dark cycle in the animal house. Animals were fed with commercial pellet diet and water ad libitum freely throughout the study.
The experimental procedure was approved by IAEC (Institutional animal ethical committee of KMCH, governed by CPCSEA, Government of India. Proposal number: KMCRET/ M.PHARM /11/2015-2016. Acute toxicity study based on a previously conducted study of Coleus vettiveroides route of administration and dosage was selected.
Isoniazid and Rifampicin Induced Hepatotoxicity in Rats: 12
Experimental Procedure: Male Wistar rats of weight between 160 - 200 g were divided into five groups with six animals in each group. Distilled water was used as a vehicle as extract was soluble in distilled water.
Group 1 was a vehicle-treated group, administered with distilled water (1 ml/kg, p.o.). Group 2 was toxic control group, administered orally with isoniazid (15 mg/kg) and rifampicin (10 mg/kg) and dissolved in water for 21 days. Group 3 was standard drug group administered with Silibinin (100 mg/kg, p.o.) suspended in 1% carboxymethyl cellulose. Group 4 and 5 were test groups, administered with EECV at 200 mg/kg, p.o, and 400 mg/kg, p.o. respectively with isoniazid and rifampicin. The vehicle, extract, and Silibinin was administered 1 h before isoniazid and rifampicin administration, each day for 21 days. 24 h after last dosing blood sample was collected through retro-orbital puncture and animals were sacrificed by cervical dislocation under general anesthesia. The liver was collected for estimation of enzymes involved in oxidative stress and histopathological examination.
Estimation of Biochemical Parameters: The cell supernatant was collected separately after in-vitro treatment and the supernatant was used to measure concentration of Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and Alkaline phosphatase (ALP) as an indication of cell necrosis. The results were expressed as units per liter (U/L). Also the biochemical parameters such as AST, ALT, ALP and total bilirubin were studied using serum after in-vivo drug treatment.
Aspartate Amino Transferase (AST): 13
Method: Optimized UV test according to the IFCC (International Federation of Clinical Chemistry and laboratory medicine)
Assay Procedure: 800 µl of reagent 1 (R1) was mixed with 200 µl of reagent 2 (R2). 100 µl of serum was added to this mixture. Mixed well and sample was analyzed using Photometer 5010v5+. Normal range: < 37 u/l.
Alanine Amino Transferase (ALT): 14
Method:
Kinetic UV Test: According to the international federation of clinical chemistry and laboratory medicine (IFCC).
Assay Procedure: 800 µl of reagent 1 (R1) was mixed with 200 µl of reagent 2 (R2). 100 µl of serum was added to this mixture. Mixed well and sample was analyzed using Photometer 5010v5+ Normal range: < 41 u/l.
Alkaline Phosphatase (ALP): 15
Procedure: 800 µl of reagent 1 (R1) was mixed with 200 µl of reagent 2 (R2). 100 µl of serum was added to this mixture. The sample was mixed well and was analyzed using Photometer 5010v5+. Normal range: 53-128 u/l.
In-vivo Antioxidant Activity: 16, 17
Preparation of Tissue Homogenate: The animals were sacrificed after treatment and liver were isolated for in-vivo antioxidant studies. The separated liver, each weighing 0.5 g were homogenized with motor-driven Teflon coated homogenizer with 5ml of ice-cold 0.1 M Tris-HCl buffer of pH 7.4 to get 10% homogenate. The homogenate was centrifuged at 10000 rpm for 20 min at 50 ºC. The supernatant was collected and used for the estimation of in-vivo antioxidant activity.
Estimation of Total Protein: Total protein content of the granular tissue was determined by following Lowry et al., (1951).
Procedure: 0.1 ml homogenate was made up to 1 ml with distilled water and 5 ml of alkaline solution was added, mixed well and allowed to stand for 10 min. Then, 0.5 ml Folin’s reagent was added, mixed well and incubated at room temperature for another 10 min. The blue color developed was measured at 640 nm against blank. Bovine serum albumin (1 mg/ml) served as the standard and from the standard graph obtained the amount of protein in the sample was calculated and expressed as mg/ 100 mg tissue.
Enzymatic Anti-Oxidant Activity:
A) Estimation of Catalase (CAT): 18
Procedure: To 1 ml of tissue homogenate 4 ml of hydrogen peroxide and 5 ml of phosphate buffer was added and mixed well. From this, 1 ml of solution was taken and mixed with dichromate acetic acid reagent and allowed to incubate for 30 min at room temperature. The absorbance was measured at 570 nm.
B) Estimation of Superoxide Dismutase (SOD):
Procedure: This method might be used for determination of the antioxidant activity of a sample, and it was described by McCord and Fridovich. The main purpose of this method that was estimated 5% of tissue homogenate after adding 75 mm, 30 mm and 2 mm from Tris-HCl (pH 8.2), EDTA, and pyrogallol respectively. Then, the absorbance was measured at 420 nm.
The percentage of inhibition was calculated depending on that the ability of the enzyme to inhibit oxidation. So, any changes might have happened on the absorbance; it will give a clear picture of the ability of enzyme activity to prevent oxidation.
C) Estimation of Glutathione Peroxidase (GPX):
Procedure: To 0.1 ml of the tissue homogenate, 0.2 ml of EDTA, sodium azide, hydrogen peroxide were added and mixed. Then 0.4 ml of phosphate buffer was added and allowed to incubate at room temperature. The reaction was arrested by the addition of 0.5 ml of TCA. The reaction mixture was centrifuged at 5000 rpm for 10 min, and the supernatant was collected. To 0.5 ml of the supernatant 4 ml of disodium hydrogen phosphate and 0.5 ml of DTNB were added and the color developed was read immediately at 420 nm. The activity of Glutathione peroxidase was expressed as units/mg protein.
Non-Enzymatic Antioxidant Activity:
Estimation of Reduced Glutathione (GSH):
Procedure: To 1 ml of the homogenate, 1 ml of the TCA solution was added and centrifuged. The supernatant was collected, and the precipitate formed was removed. To 0.5 ml of supernatant 2 ml of DTNB was added, the volume was made up to 3 ml with phosphate buffer. Then absorbance was read at 412 nm. The amount of glutathione was expressed as μg/mg protein.
Determination of Lipid Peroxidation:
Procedure: To 0.1 ml of the sample, 2 ml of TBA-TCA-HCl reagent (ratio of 1:1:1) was added, mixed and kept in a water bath for 15 min. Afterward, the solution was cooled and supernatant was removed. The absorbance was measured at 535 nm against reference blank. The level of lipid peroxidase was given as n moles of MDA formed/mg protein.
Histopathological Techniques: Histopathology is the microscopical study of tissues for pathological alterations. This involves the collection of morbid tissues from biopsy or necropsy, fixation, preparation of sections, staining and microscopical examination.
Collection of Materials: Thin pieces of 3 to 5 mm, thickness were collected from liver tissues showing gross morbid changes along with normal tissue.
Fixation: Kept the tissue in fixative for 24 - 48 h at room temperature. The fixation was useful in the following ways:
a. Serves to harden the tissues by coagulating the cell protein.
b. Prevents autolysis.
c. Preserves the structure of the tissue.
d. Prevents shrinkage.
Common Fixatives: 10% Formalin.
Hematoxylin and Eosin Method of Staining: Deparaffine the section by xylol 5 to 10 min and remove xylol by absolute alcohol. Then cleaned the section in tap water and stained with hematoxylin for 3 - 4 min and again cleaned under tap water.
Allow the sections in tap water for a few minutes and counterstained with 0.5% eosin until section appears light pink for 15 to 30 sec and then washed in tap water. Blotted and dehydrated in alcohol and cleared with xylol for 15 to 30 sec.
Mounted on Canada balsam or DPX Moutant and kept the slide dry and remove air bubbles.
Statistical Analysis: Statistical analysis data were expressed as mean ± SEM and statistical analysis was carried out by using Graph Pad 5.0 software by applying one-way ANOVA with Dunnet’s test. P < 0.05 was considered to be significant.
Results:
In-vitro Antioxidant Activity:
DPPH Radical Scavenging Activity:
TABLE 1: PERCENTAGE INHIBITION AND IC50 VALUES OF DPPH RADICAL BY QUERCETIN AND EECV
Sample | Concentration (µg/ml) | % Inhibition | IC50 (µg/ml) |
EECV | 10 | 23.90 | 47.27 |
20 | 30.94 | ||
40 | 40.87 | ||
60 | 51.29 | ||
80 | 59.61 | ||
100 | 76.63 | ||
Standard
(Quercetin) |
5 | 45.79 | 6.560 |
10 | 58.87 | ||
15 | 69.15 | ||
20 | 78.47 | ||
25 | 90.54 | ||
30 | 96.89 |
BTS Radical Scavenging Activity:
TABLE 2: PERCENTAGE INHIBITION OF ABTS RADICAL BY ASCORBIC ACID AND EECV
Sample | Conc. (µg/ml) | % Inhibition | IC50 (µg/ml) |
EECV | 5 | 69.18 | 2.738 |
10 | 76.6 | ||
15 | 82.61 | ||
Standard
(Quercetin) |
20 | 88.3 | 0.1902 |
25 | 98.67 | ||
30 | 99.38 | ||
0.25 | 62.57 | ||
0.5 | 69.17 | ||
0.75 | 78.04 | ||
1 | 85.75 | ||
1.25 | 99.38 | ||
1.5 | 99.48 |
Determination of Cell Viability by MTT Assay:
TABLE 3: PERCENTAGE CELL VIABILITY AFTER TREATMENT WITH EECV AND STANDARD
Sample | Conc. (µg/ml) | % Cell viability |
EECV | 12.5 | 100.2169 |
25 | 99.4938 | |
50 | 97.9031 | |
100 | 96.3123 | |
200 | 93.0585 | |
Standard (Silybinin) | 6.25 | 100.5 |
12.5 | 99.60 | |
25 | 107.48 | |
50 | 104.92 | |
100 | 74.63 |
In-vitro Hepatoprotective Activity:
TABLE 4: IN-VITRO HEPATOPROTECTIVE ACTIVITY OF EECV AGAINST CCl4 INDUCED HEPATO-TOXICITY IN HEP G2 CELL LINES
Group | %Cell Viability | AST (U/L) | ALT (U/L) | ALP (U/L) |
Group 1: Normal (Only medium) | 100 | 15.00 ± 1.732 | 11.33 ± 2.603 | 28.33 ± 2.906 |
Group 2: Toxicant (CCl4) | 33.33 | 64.33 ± 2.728 | 84.67 ± 6.936 | 200.3 ± 15.88 |
Group 3: CCl4 + 25 µg/ml Standard
CCl4 + 50 µg/ml Standard CCl4 + 100 µg/ml Standard |
151.56
197.64 189.21 |
23.33 ± 1.453
20.67 ± 2.848 19.00 ± 1.528 |
27.00 ± 2.646
16.67 ± 2.906 15.67 ± 2.906 |
68.67 ± 4.055
50.00 ± 3.786 31.33 ± 3.180 |
Group 4: CCl4 + 50 µg/ml EECV
CCl4 + 100 µg/ml EECV Cl4 + 200 µg/ml EECV |
83.45
110.56 134.42 |
29.67 ± 4.055
20.33 ± 2.603 18.00 ± 3.215 |
24.00 ± 1.000
22.67 ± 1.202 21.33 ± 3.180 |
149.7 ± 5.487
64.00 ± 1.528 60.67 ± 1.764 |
In-vivo Hepatoprotective Activity:
TABLE 5: EFFECT OF EECV ON BIOCHEMICAL PARAMETERS IN INH+RIF INDUCED HEPATOTOXIC RATS
Group | AST (U/L) | ALT (U/L) | ALP (U/L) | Total bilirubin (mg/dl) |
Normal | 48.00 ± 2.769 | 45.17 ± 4.715 | 127.7 ± 3.694 | 0.2167 ± .0477 |
Control INH+RIF
(15, 10 mg/kg) |
171.5 ± 10.65*** | 160.3 ± 12.94*** | 352.0 ± 26.18*** | 0.5500 ± .0562*** |
Standard Silibinin
(100 mg/kg) |
65.6 7± 2.201*** | 61.33 ± 6.048*** | 143.3 ± 2.404*** | 0.2833 ± .0401** |
EECV (200 mg/kg) | 116.2 ± 4.301*** | 101.5 ± 6.433*** | 211.3 ± 5.548*** | 0.3500 ± .0619ns |
EECV (400 mg/kg) | 95.50 ± 7.284*** | 88.50 ± 3.149*** | 179.5 ± 4.530*** | 0.3000 ± 0.0365* |
Estimation of Total Protein:
TABLE 6: EFFECT OF EECV ON TOTAL PROTEIN IN LIVER TISSUE, VALUES EXPRESSED IN MG/G OF TISSUE
Treatment | Total proteins (mg/100 mg tissue) |
Normal | 7.14 5 ± 0.5921 |
Control (INH+RIF) | 3.313 ± 0.6290*** |
Silibinin (100 mg/kg) | 6.125 ± 0.5715** |
EECV (200 mg/kg) | 4.917 ± .0703ns |
EECV (400 mg/kg) | 5.533 ± 0.5602* |
In-vivo Antioxidant Study:
TABLE 7: EFFECT OF EECV ON LIVER ANTIOXIDANT ENZYMES AND LIPID PEROXIDATION
Treatment | Catalase (µM of H2O2/mg protein) | SOD
(U/mg protein) |
GPX
(U/mg protein) |
GSH (µg of GSH/mg protein) | Lipid peroxidation (nM of MDA/mg protein) |
Normal | 34.67 ± 1.783 | 3.375 ± 0.1948 | 29.02 ± 0.5776 | 17.61 ± 0.8516 | 6.158 ± 0.5598 |
Control (INH+RIF) | 15.50 ± 1.118*** | 0.9067 ± 0.025*** | 15.10 ± 1.32*** | 8.05 ± 1.41*** | 24.25 ± 1.182*** |
Standard (Silibinin) | 29.50 ± 0.6191*** | 2.507 ± 0.1434*** | 25.15 ± 0.596*** | 14.17 ± 0.9426** | 9.05 ± 0.5795*** |
EECV (200 mg/kg) | 20.53 ± 0.8353* | 1.527 ± 0.0729* | 20.03 ± 0.578** | 10.02 ± 1.644ns | 17.07 ± 0.5737*** |
EECV (400 mg/kg) | 27.05 ± 1.167*** | 2.027 ± 0.1884*** | 22.08 ± 0.583*** | 13.08 ± 0.7926* | 12.02 ± 0.5776*** |
Histopathology:
GROUP | 10X | 40X |
Group 1: Normal | ||
Group 2: Control
(INH-RIF only) |
||
Group 3: Silibinin
(100 mg/kg) |
||
Group 4: EECV
(200 mg/kg) |
||
Group 5: EECV
(400 mg/kg)
|
DISCUSSION: The liver may be considered as one of the most important organs in drug toxicity for two reasons: on the one hand it is functionally interposed between the site of absorption and the systemic circulation and is the main site of metabolism and elimination of foreign substances, but on the other hand these features also render it a preferred target for drug toxicity. Phytochemical screening of EECV was carried out, and the results showed the presence of carbohydrates, alkaloids, tannin, flavonoids, phenolics, proteins and aminoacid, steroids and triterpenoids.
It is suggested that the phytoconstituents like flavonoids and phenolics mediate their antioxidant effects by scavenging free radicals and/or by chelating metal ions which aid in the hepatoprotective activity of EECV. HPTLC screening of EECV was carried out along with different marker compounds to ensure the presence of phytoconstituents such as quercetin, rutin, and gallic acid. From the result of HPTLC analysis it was found that EECV contains phytoconstituents like gallic acid and quercetin. Percentage of Gallic acid and Quercetin in 100 mg of extract by HPTLC quantification was found to be 1.37% and 1.08% respectively. Antioxidant activities of the herbal extract were determined using both DPPH and ABTS scavenging method. The IC50 value of EECV and quercetin was found to be 47.27 μg/ml and 6.560 μg/ml respectively.
From the results obtained in ABTS assay it was found that the extract scavenged ABTS radicals generated by the reaction between ABTS and potassium persulphate.
The activity was found to be increased in a dose-dependent manner. IC50 value of quercetin and EECV was found to be 0.1902 μg/ml and 2.738 μg/ml respectively. MTT assay is most widely used to determine the cytotoxic potential of medicinal agents and other toxic materials. It was observed that for different concentrations of EECV, the cell viability was greater than 90%. The cell viability of EECV at concentration 200 μg/ml is 93.0585% and for standard silybinin the percentage cell viability at concentration 100 μg/ml is 74.63%. In the present study, hepatotoxicity model in Wistar rats was successfully produced by administering INH and RIF (15 and 10 mg/kg respectively) orally. In the present study administration of INH and RIF in Wistar rats produced a significant increase in AST, ALT, ALP and total bilirubin levels confirming hepatocellular damage. Treatment with EECV 200, 400 mg/kg significantly attenuated these changes in a dose-dependant manner. There was significant increase in AST, ALT, ALP and total bilirubin in control group compared to normal group. Treatment with EECV and Silibinin showed significant decrease in AST, ALT, ALP, and total bilirubin levels. The results were tabulated in table and figures.
The hepatoprotective effect of EECV may be due to the ability to act as a free radical scavenger, thereby protecting membrane permeability. Enhanced oxidative stress in antitubercular drug-treated animals was confirmed based on altered profile of antioxidant enzymes and increased lipid peroxidation. SOD is a class of closely related enzymes that catalyze the breakdown of the superoxide anion into oxygen and hydrogen peroxide. Catalases are enzymes that catalyze the conversion of hydrogen peroxide to water and oxygen, using either an iron or manganese cofactor. The biochemical function of glutathione peroxidase is to reduce lipid hydroperoxides to their corresponding alcohols and to reduce free hydrogen peroxide to water.
Increasing one’s glutathione levels help the productivity of the glutathione peroxidase and vice versa. Lipid peroxidase is the enzyme involved in oxidative degradation of lipids. In the process free radicals steal electrons from the lipids in cell membranes, resulting in cell damage. This process proceeds by a free radical chain reaction mechanism. It most often affects polyunsaturated fatty acids, because they contain multiple double bonds in between which lie methylene groups that possess reactive hydrogen 13. In the toxic control group, the level of SOD, GSH, GPX, and catalase was significantly lower, and LPO level was significantly higher. This confirmed the induction of oxidative stress due to administration of isoniazid and rifampicin in toxic control group. At both of the selected doses of extract, significant protection against oxidative stress was observed with increase in level of SOD, GSH, GPX, and catalase and decrease in LPO level.
Also the total protein level was significantly lower in the toxic group treated with INH and RIF only and the level was significantly higher in standard and extract-treated groups. The protective effects of EECV were further confirmed by histopathological examination of the livers, showing marked protection against liver tissue damage, normal lobular architecture, dilated sinusoidal spaces and vacuolization as compared to controls.
CONCLUSION: Liver is a versatile organ in the body concerned with the regulation of internal chemical environment. Therefore, damage to liver caused by hepatotoxic agents is of grave consequence. There is an ever-increasing need for an agent which could protect liver damage.
The present study reveals that the roots of Coleus vettiveroides possess hepatoprotective activity in CCl4 and INH-RIF induced hepatotoxicity. It showed significant antioxidant activity by terminating the actions of free radicals. The extract reduced the elevated serum biochemical parameters such as AST, ALT, ALP and total bilirubin. The level of in-vivo antioxidant parameters such as catalase, SOD, GPX, and GSH was restored in liver tissues. The potential hepatoprotective activity of EECV may be due to the presence of phenols and flavonoids by scavenging free radicals and/or by chelating metal ions which aid in the hepatoprotective activity of EECV.
ACKNOWLEDGEMENT: Authors are thankful to the Management of KMCH College of Pharmacy, Coimbatore for their support in the form of providing facilities.
CONFLICTS OF INTEREST: The authors declare no conflicts of interest.
REFERENCES:
- Majee C, Mazumder R and Choudhary AN: Medicinal plants with anti-ulcer and hepatoprotective activity: a review. Int J Pharm Sci & Res 2019; 10(1): 1-11.
- Puri SK, Habbu PV, Kulkarni PV and Kulkarni VH: Hepatoprotective activity of fungal endophytic fractions of Andrographis paniculata (burm. F.) Wall nees. leaves in Paracetamol and ethanol induced hepatotoxicity. Int J Pharm Sci & Res 2019; 10(1): 97-107.
- Sirisha SNVL, Prabhu K and Rao AS: Hepatoprotective activity of berry extracts of Diospyros kaki against carbon tetrachloride induced liver damage model. Int J of Pharm Sci & Res 2019; 10(1): 381-86.
- Soni H and Singhai AK: Recent updates on the genus coleus: a review. Asian J Pharm Clin Res 2012; 5(1): 12-7.
- Gopalakrishnan G and Dhanapal CK: Evaluation of anti-diabetic activity of methanolic extract of Coleus vettiveroides jacob in streptozotocin-induced diabetic rats. J Pharm Sci & Res 2014; 6(2): 97-103.
- Jaslin EJ and Padmaja V: Anti-cancer activity of Coleus vettiveroidesc jacob Dalton’s ascitic lymphoma. Int J of Trends in Pharmacy and Sciences 2015; 1(5): 553-57.
- Lakshmanashetty RH, Nagaraj VB, Hiremuth MG and Kumar V: In-vitro antioxidant activity of Vitex negundo leaf extract. Chiang Mai. J Sci 2010; 37(3): 489-97.
- Blois MS: Antioxidant determinations by the use of a stable free radical. Nature 1958; 181: 1199-00.
- Estrada MJB, Conteras CV and Escobar AG: In-vitro anti-oxidant and anti-proliferative activities of plants of the ethnopharmacopeia from northwest of Mexico. BMC Complementary and Alternative Medicine 2013; 13: 12.
- Re R, Pellegrini N, Proteggente A, Pannala A and Yang M: Rice - evans c. Anti-oxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999; 26(9-10): 1231-37.
- Gite S, Yadav S, Nilegaonkar S and Agte V: Evaluation of hepatoprotective potential of functional food formulations using in-vitro and in-vivo models of CCl4 radical induced toxicity.
- Pareek A, Godavarthi A, Issarani R and Nagori BP: Anti-oxidant and hepatoprotective activity of Fagonia schweinfurthii (Hadidi) Hadidi extract in carbon tetrachloride-induced hepatotoxicity in HepG2 cell line and rats. J of ethnopharmacology 2013; 150(3): 973-81.
- Samuel AJ, Mohan S, Chellappan DK, Kalusalingam A and Ariamuthu S: Hibiscus vitifolius (Linn.) root extracts shows potent protective action against anti-tubercular drug induced hepatotoxicity. Journal of ethnopharmacology. 2012; 141(1): 396-02.
- Prabakan M, Anandan R and Devaki T: Protective effect of indicus against rifampicin and isoniazid-induced hepatotoxicity in rats. Fitoterapia 2000; 71(1): 559.
- IFCC Methods for the measurement of catalytic concentration of enzymes. J Clin Chem Clin biochem 1986; 24: 497.
- Sinha AK: Colorimetaaric assay of catalase Anal Biochem 1972; 47: 389-95.
- Marklund S and Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European Journal of Biochemistry 1974; 47(3): 469-74.
- Al-Temimi A and Choudhary R: Determination of antioxidant activity in different kinds of plants in-vivo and in-vitro by using diverse technical methods. Journal of Nutrition & Food Sciences 2013.
- Okawa HN, Ohishi K and Yagi M: Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95(2): 351-58.
How to cite this article:
Abarnadevika A and Nisha TR: Evaluation of hepatoprotective activity of Coleus vettiveroides roots on experimentally induced hepato toxic models. Int J Pharm Sci & Res 2020; 11(2): 765-73. doi: 10.13040/IJPSR.0975-8232.11(2).765-73.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
32
765-773
730
752
English
IJPSR
A. Abarnadevika * and T. R. Nisha
KMCH College of Pharmacy, Affiliated by the Tamil Nadu Dr. MGR Medical University, Coimbatore, Tamil Nadu, India.
abarnadevika@gmail.com
04 May 2019
19 August 2019
01 September 2019
10.13040/IJPSR.0975-8232.11(2).765-73
01 February 2020